spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  CRESCENDO 

 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Jan 2016
Counsyl Appoints Ted Snelgrove as Chief Business Officer
Diagnostics Personnel
 HSMN NewsFeed - 16 Dec 2014
Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody(TM) Therapeutics Targeting Immune Checkpoint Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Nov 2014
Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR
Diagnostics
 HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Dec 2013
Crescendo Biologics Raises £17.5M ($28M) in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Mar 2008
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2007
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Elusys Announces Collaborative Research and License Agreement with Pfizer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Sep 2006
Cordis Corporation and Brivant Limited Sign Distribution Agreement for Three Interventional Products
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 13 Jul 2006
Elusys Therapeutics Completes $23 Million Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jun 2006
Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for New Balloon Dilation Catheter
Devices Distribution Interventional Cardiology
Return to NewsFeed  

 Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 1 additional stories matching:
CRESCENDO
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!